Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer

PURPOSE: To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) from the perspective of the Canadian public healthcare system. METHODS: We developed a Markov st...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hannouf, Malek B., Sehgal, Chander, Cao, Jeffrey Q., Mocanu, Joseph D., Winquist, Eric, Zaric, Gregory S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3379991/
https://ncbi.nlm.nih.gov/pubmed/22745668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0038557
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak